Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes

AIMS/INTRODUCTION: Early initiation of basal insulin therapy is recommended for normalizing fasting blood glucose in type 2 diabetes mellitus. However, basal insulin treatment might not adequately control postprandial glucose levels. The present study evaluated whether the combination of the α-gluco...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji-Hyun, Ahn, Ji-Hyun, Kim, Soo-Kyung, Lee, Dae-Ho, Kim, Hye-Soon, Shon, Ho-Sang, Jeon, Hyun-Jeong, Kim, Tae-Hwa, Cho, Yong-Wook, Kim, Jae-Taek, Han, Sung-Min, Chung, Choon-Hee, Ryu, Ohk-Hyun, Lee, Jae-Min, Lee, Soon-Hee, Kwon, Min-Jeong, Kim, Tae-kyun, Namgoong, Il-Seong, Kim, Eun-Sook, Jung, In-Kyung, Moon, Sung-Dae, Han, Je-Ho, Kim, Chong-Hwa, Cho, Eun-Hee, Kim, Ki-Young, Park, Hee-Baek, Lee, Ki-Sang, Lee, Sung-Woo, Lee, Sang-Cheol, Kang, Cheol-Min, Jeon, Byung-Sook, Song, Min-Seop, Yun, Seung-Baik, Chung, Hyung-Keun, Seong, Jong-Ho, Jeong, Jin-Yi, Cha, Bong-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364857/
https://www.ncbi.nlm.nih.gov/pubmed/25802730
http://dx.doi.org/10.1111/jdi.12261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364857/
https://www.ncbi.nlm.nih.gov/pubmed/25802730
http://dx.doi.org/10.1111/jdi.12261

Ejemplares similares